$PHR 4/A SEC Filings

Filed On	Filing
28 Mar 2025	Form 4/A: Cahill Edward L, Director Holds 54,976 shares of Common Stock
28 Mar 2025	Form 4/A: Weintraub Michael, Director Holds 37,479 shares of Common Stock
23 Mar 2023	Form 4/A: Munson Gillian, Director Gave up 1,449 shares to cover exercise price or tax ($24K)
23 Feb 2022	Form 4/A: Pegus Cheryl, Director Holds 0 shares of Common Stock
10 Sep 2021	Form 4/A: Linetsky David, SVP, Life Sciences Exercised 1,377 Stock Option (Right to Buy)
10 Sep 2021	Form 4/A: Linetsky David, SVP, Life Sciences Exercised 1,376 Stock Options (Right to buy)
10 Sep 2021	Form 4/A: Linetsky David, SVP, Life Sciences Exercised 1,376 Stock Options (Right to buy)
16 Sep 2020	Form 4/A: Goldstein Lainie, Director Received 11,291 shares as a grant or award
15 Jun 2020	Form 4/A: Davidoff Michael J., See Remarks Received 4,284 shares by exercise or conversion ($34.4K) · Sold 4,284 shares ($86.1K)
15 Jun 2020	Form 4/A: Davidoff Michael J., See Remarks Received 1,404 shares by exercise or conversion ($11.3K) · Sold 1,404 shares ($28.3K)
12 Feb 2020	Form 4/A: Davidoff Michael J., See Remarks Sold 4,550 shares ($151K)
05 Feb 2020	Form 4/A: Roberts Evan, Chief Operating Officer Received 5,445 shares by exercise or conversion ($11.1K) · Sold 69,448 shares ($2.03M)
22 Jan 2020	Form 4/A: Davidoff Michael J., See Remarks Received 21,210 shares by exercise or conversion ($30.9K)
22 Jan 2020	Form 4/A: Linetsky David, See Remarks Received 3,413 shares by exercise or conversion ($2.49K)
22 Jan 2020	Form 4/A: Davidoff Michael J., See Remarks Received 1,545 shares by exercise or conversion ($1.13K)

Comments